Sun Pharma shines on reporting round 4-fold leap in Q3 consolidated net profit by admin- Wednesday, February 13th, 2019 04:12:32 PM
Sun Pharmaceutical Industries is presently buying and selling at Rs. 448.75, up by 12.00 points or 2.75% from its preceding closing of Rs. 436.Seventy five on the BSE.
The scrip opened at Rs. 451.50 and has touched a excessive and occasional of Rs. 454.Forty and Rs. 445.Eighty five respectively. So a ways 496017 stocks were traded at the counter.
The BSE organization ‘A’ inventory of face fee Rs. 1 has touched a fifty two week high of Rs. 678.80 on 06-Sep-2018 and a fifty two week low of Rs. 375.Forty on 18-Jan-2019.
Last one week high and coffee of the scrip stood at Rs. 454.Forty and Rs. 421.00 respectively. The contemporary marketplace cap of the organisation is Rs. 104790.95 crore.
The promoters protecting within the enterprise stood at 54.38%, at the same time as Institutions and Non-Institutions held 32.53% and thirteen.09% respectively.
Sun Pharmaceutical Industries has reported a net loss of Rs 38.68 crore for the region ended December 31, 2018 against net profit of Rs 320.65 crore for the identical sector in the previous year. Total profits of the organisation decreased by way of 6.26% at Rs 2289.02 crore for Q3FY19 compared Rs 2441.Ninety crore for the corresponding sector previous yr.
On the consolidated basis, the organisation has suggested around 4-fold jump in its internet earnings at Rs 1,241.Eighty five crore for the quarter ended December 31, 2018 compared to Rs 321.57 crore for the equal region in the previous year. Total earnings of the organisation elevated by using sixteen.Ninety seven% at Rs 7,933.25 crore for Q3FY19 compared Rs 6,782.Forty two crore for the corresponding quarter preceding yr.